DnB Asset Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46M Buy
22,041
+17,839
+425% +$1.51M ﹤0.01% 616
2026
Q1
$418K Buy
+4,202
New +$548K ﹤0.01% 825
2025
Q4
Sell
-29,691
Closed -$3.33M 774
2025
Q3
$3.33M Buy
29,691
+19,787
+200% +$2.32M 0.01% 508
2025
Q2
$1.33M Sell
9,904
-36,973
-79% -$4.06M 0.01% 606
2025
Q1
$3.15M Buy
46,877
+16,662
+55% +$1.15M 0.01% 474
2024
Q4
$1.88M Buy
30,215
+25,834
+590% +$2.4M 0.01% 589
2024
Q3
$688K Buy
4,381
+2,935
+203% +$452K ﹤0.01% 643
2024
Q2
$218K Sell
1,446
-3,070
-68% -$368K ﹤0.01% 693
2024
Q1
$334K Buy
+4,516
New +$372K ﹤0.01% 673

Other funds holding TMDX

DnB Asset Management's TMDX Position: Q2 2026 in Review

DnB Asset Management increased its Transmedics (TMDX) stake by 425% in Q2 2026, buying an estimated $1.51M and bringing the position to 22,041 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #616.

DnB Asset Management first reported a position in TMDX in Q1 2024 and has held it in 9 quarters since. The position peaked at $3.33M in Q3 2025. 284 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • DnB Asset Management held 22,041 shares of Transmedics worth $1.46M as of Q2 2026.
  • DnB Asset Management bought 17,839 Transmedics shares in Q2 2026, an estimated $1.51M.
  • Transmedics made up ﹤0.01% of DnB Asset Management's portfolio in Q2 2026, its #616 holding.
  • DnB Asset Management first reported a position in Transmedics in Q1 2024 and has held it in 9 quarters since.
  • DnB Asset Management's Transmedics position peaked at $3.33M in Q3 2025.
  • 284 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.